Saturday, October 31, 2026

Superhenge not Aligned With Winter Solstice Like Stonehenge

Mark Silva

September 7, 2015

Stonehenge is aligned with the winter solstice. Image by Simon Wakefield - License
The British Science Association announced today the discovery of about 200 standing stones (called Superhenge) just under two miles (3km) away from the Stonehenge.
"The overlying bank surrounding the Superhenge is aligned with the winter solstice, but the buried monument seems to be on a different alignment."

Professor Vince Gaffney

Recent scanning of the area with remote sensing and image technology has already unveiled 4.5 meters tall standing stones expected to be about 4500 years old. The Superhenge, called Durrington Walls, has been lost to archeology up until now and could be the largest intact prehistoric monument in Great Britain. In an interview to the BBC world news, Professor Vince Gaffney of the University of Bradford said that the overlying bank surrounding the Superhenge alignment with the winter solstice, but the buried monument seems to be on a different alignment. The original purpose of the Stonehenge is still a mystery that maybe the 15 times bigger Superhenge discovery could help to unveil.
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com